在智利2型糖尿病患者中,感知到的社会支持和治疗坚持
Belén Salinas-Rehbein1, Manuel S Ortiz2, Theodore F Robles3
1Department of Psychology, Universidad Católica de Temuco, Chile.
Journal of health psychology
|May 29, 2024
概括
更大的社会支持改善了2型糖尿病 (T2D) 治疗的坚持,包括饮食和运动. 这种坚持反过来又与智利成年人的血糖水平 (HbA1c) 降低有关.
科学领域:
- 内分泌学和新陈代谢学
- 行为医学是一种行为医学.
- 公共卫生 公共卫生
背景情况:
- 2型糖尿病 (T2D) 管理需要患者始终遵守治疗计划.
- 社会支持是影响健康行为的一个公认因素,但它在T2D坚持方面的具体作用需要进一步阐明.
- 了解这些关联可以为各种人群提供文化相关的干预信息.
研究的目的:
- 调查感知到的社会支持与2型糖尿病治疗坚持之间的直接关联.
- 检查2型糖尿病治疗坚持和血糖控制 (HbA1c水平) 之间的关系.
- 探索这些联系在智利成年人被诊断为T2D的队列中.
主要方法:
- 一项涉及200名来自智利糖尿病协会招募的T2D成年人的横截面研究.
- 数据收集包括自我报告问卷,评估感知到的社会支持和治疗坚持行为.
- 通过毛细血管血液样本测量HbA1c水平;结构方程建模分析了直接关联.
主要成果:
- 感知到的社会支持的增加与更健康的饮食习惯,定期的脚部护理,增加的体力活动和减少的药物制有显著的关联.
- 血糖监测和体育活动与较低的HbA1c水平有联系.
- 这些发现强调了社会支持在促进特定T2D治疗坚持行为的作用.
结论:
- 感知到的社会支持是南美拉丁裔患者2型糖尿病治疗坚持行为的关键决定因素.
- 旨在增强家庭,伴侣和朋友的社会支持的干预措施可以改善坚持和血糖控制.
- 这些结果强调了社交网络在管理T2D等慢性疾病方面的重要性.
相关概念视频
Diabetes: Management and Pharmacotherapy
265
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
265
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Carbohydrate Metabolism
11.0K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.0K
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Oral Hypoglycemic Agents: Biguanides and Glitazones
192
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
192
Insulin: Dosing Regimen and Adverse Effects
167
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
167


